The White House withdraws Dr. Heidi Overton’s nomination to become commissioner of the U.S. Food and Drug Administration, after the nomination faced uncertainty ahead of a Senate health committee vote. Multiple outlets report that the decision is confirmed by White House officials and comes shortly before lawmakers were scheduled to consider her.
Several sources connect the withdrawal to the question of whether Overton had sufficient support for Senate confirmation. The Guardian and others frame the move in the context of her political profile and anticipated opposition, while MedPage Today, The Hill, and The New York Times emphasize that it became clear she did not have the votes needed to win confirmation. Fox News and other outlets similarly stress the timing on the eve of the committee panel vote.
Overall, coverage largely agrees on the central development—withdrawal of the FDA nomination—and on the immediate political setting: a planned Senate committee action with closely divided Republican support. Differences mainly lie in how much background each outlet adds about why support was lacking and how the decision is interpreted.